1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Immunochemistry Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Immunochemistry Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. North America Immunochemistry Market Regional Analysis
6.1 North America Immunochemistry Market Overview
6.2 North America Immunochemistry Market Revenue 2016-2027 (US$ Million)
6.3 North America Immunochemistry Market Forecast Analysis
7. North America Immunochemistry Market Analysis – by Application
7.1 Diagnostics
- 7.1.1 Overview
- 7.1.2 Diagnostics: North America Immunochemistry Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Drug Testing
- 7.2.1 Overview
- 7.2.2 Drug Testing: North America Immunochemistry Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Immunochemistry Market Analysis – by Product
8.1 Antibodies
- 8.1.1 Overview
- 8.1.2 Antibodies: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Equipment
- 8.2.1 Overview
- 8.2.2 Equipment: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Reagents
- 8.3.1 Overview
- 8.3.2 Reagents: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Kits
- 8.4.1 Overview
- 8.4.2 Kits: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Immunochemistry Market Analysis – by End User
9.1 Hospitals and Diagnostic Laboratories
- 9.1.1 Overview
- 9.1.2 Kits: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Research Institutes
- 9.2.1 Overview
- 9.2.2 Kits: North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Immunochemistry Market – North America Analysis
10.1 North America
- 10.1.1 North America Immunochemistry Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.1.1.1 North America Immunochemistry Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Immunochemistry Market Breakdown, by Application
- 10.1.1.1.2 US: North America Immunochemistry Market Breakdown, by Product
- 10.1.1.1.3 US: North America Immunochemistry Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Immunochemistry Market Breakdown, by Application
- 10.1.1.2.2 Canada: North America Immunochemistry Market Breakdown, by Product
- 10.1.1.2.3 Canada: North America Immunochemistry Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Immunochemistry Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Immunochemistry Market Breakdown, by Application
- 10.1.1.3.2 Mexico : North America Immunochemistry Market Breakdown, by Product
- 10.1.1.3.3 Mexico : North America Immunochemistry Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Immunochemistry Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 PerkinElmer, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Abcam Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Agilent Technologies,
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bio SB
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bio-Rad Laboratories, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Cell Signalling Technology, Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Danaher
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Merck KGaA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Immunochemistry Market
